CIK: 1652179 - Address: C/o Inozyme Pharma, Inc., 321 Summer Street Suite 400, Boston, MA 02210
4 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret111-2-1-8-3600-12
S%wins100100100100100

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/19/22 08:30
12/15/22
INZYInozyme Pharma, Inc.DEHealthDrugPharmaceutical PreparationsBjarke Henric BjornMAOSVP,COOP301.3902226105D
4/20/22 16:05
4/19/22
INZYInozyme Pharma, Inc.DEHealthDrugPharmaceutical PreparationsBjarke Henric BjornMAOSVP,COOP1003.690275181D
1/6/17 17:12
1/4/17
OPHTOphthotech Corp.DEHealthDrugPharmaceutical PreparationsBjarke Henric BjornNYOSVP,CCOM.d00.00261712D-89-93-91-89-871-23-2-1-8-36
1/6/17 17:12
1/5/17
OPHTOphthotech Corp.DEHealthDrugPharmaceutical PreparationsBjarke Henric BjornNYOSVP,CCOS.d-24.96260-162D-89-93-91-89-871-23-2-1-8-36

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact